Wynnefield Capital Inc.
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed July 15, 2025), Wynnefield Capital Inc. reported 16 stock positions worth $169.5 million. Its top holding was Lifecore Biomedical (LFCR) at 22.5% of the portfolio, followed by Natures Sunshine Prods (NATR, 21.6%) and Cadre (CDRE, 21.1%). Compared with Q1 2025, it reduced 2. The biggest sale was Agnico Eagle Mines (AEM, shares −44%).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001251567
- Portfolio Value
- $169.5M (Q2 2025)
- SEC Filing
- 0001104659-25-068057 ↗ filed Jul 15, 2025
Holdings Value
Holdings 16 stocks · $169.5M
| LFCR Lifecore Biomedical Inc. | 22.53% | 4,703,216 | $38.2M | No change |
| NATR Natures Sunshine Prods Inc. | 21.58% | 2,473,686 | $36.6M | No change |
| CDRE Cadre Holdings Inc. | 21.14% | 1,125,240 | $35.8M | No change |
| DLHC DLH Holdings Corp. filed as DLH HLDGS CORP | 12.68% | 3,681,421 | $21.5M | No change |
| AEM Agnico Eagle Mines Ltd. | 7.01% | 99,991 | $11.9M | Reduce -44.5% |
| STKL Sunopta Inc. | 6.76% | 1,975,784 | $11.5M | No change |
| QRHC Quest Resource Holding Corp. | 3.26% | 2,734,349 | $5.5M | No change |
| SIL Global X Silver Miners ETF | 1.42% | 50,000 | $2.4M | No change |
| TPCS Techprecision Corp. | 0.96% | 433,605 | $1.6M | No change |
| PAAS Pan American Silver Corp. | 0.84% | 50,000 | $1.4M | Reduce -50.0% |
| TLS Telos Corporation | 0.75% | 400,000 | $1.3M | No change |
| HGBL Heritage Global Inc. | 0.53% | 401,030 | $890K | No change |
| SANW S&W Seed Co. | 0.29% | 223,718 | $488K | No change |
| AVD American Vanguard Corp. | 0.12% | 50,000 | $196K | No change |
| SOTK Sono-Tek Corp. | 0.11% | 50,950 | $191K | No change |
| NNBR NN Inc. | 0.03% | 28,128 | $59K | No change |
Portfolio Sells Q1 2025 → Q2 2025
Portfolio Buys Q1 2025 → Q2 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 8 | $145.4M | NATR, CDRE, LFCR, DLHC, AEM |
| Q1 2026 | 9 | $147.5M | NATR, CDRE, DLHC, LFCR, AEM |
| Q4 2025 | 12 | $177.8M | NATR, CDRE, LFCR, DLHC, STKL |
| Q3 2025 | 15 | $166.4M | CDRE, NATR, LFCR, DLHC, STKL |
| Q2 2025 | 16 | $169.5M | LFCR, NATR, CDRE, DLHC, AEM |
| Q1 2025 | 16 | $158.0M | CDRE, LFCR, NATR, AEM, DLHC |
| Q4 2024 | 16 | $219.4M | AEM, CDRE, NATR, LFCR, DLHC |
| Q3 2024 | 17 | $224.7M | CDRE, AEM, DLHC, NATR, LFCR |
| Q2 2024 | 17 | $222.5M | CDRE, DLHC, NATR, AEM, LFCR |
| Q1 2024 | 23 | $251.7M | NATR, DLHC, CDRE, AEM, LFCR |